Cargando…

Consensus on the Screening, Staging, Treatment, and Surveillance of Localized, Recurrent, and Metastatic Prostate Cancer: The First Global Prostate Cancer Consensus Conference for Developing Countries

Detalles Bibliográficos
Autores principales:	Maluf, Fernando Cotait, Gillessen, Silke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2021
Materias:	COMMENTARIES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162967/ https://www.ncbi.nlm.nih.gov/pubmed/33856893 http://dx.doi.org/10.1200/GO.20.00518

Ejemplares similares

Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
por: Maluf, Fernando Cotait, et al.
Publicado: (2021)

Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
por: Maluf, Fernando Cotait, et al.
Publicado: (2021)

Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries
por: Monteiro, Fernando S. M., et al.
Publicado: (2021)

Consensus on Screening, Diagnosis, and Staging Tools for Prostate Cancer in Developing Countries: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
por: Carneiro, Arie, et al.
Publicado: (2021)

In-depth Analysis of the 2019 Advanced Prostate Cancer Consensus Conference: The Importance of Representation of Medical Specialty and Geographic Regions
por: Pratsinis, Manolis, et al.
Publicado: (2021)

Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries
por: Khauli, Raja, et al.
Publicado: (2021)

Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries
por: Pereira, Felipe Moraes Toledo, et al.
Publicado: (2021)

First brazilian consensus of advanced prostate cancer: recommendations for clinical practice
por: Sasse, Andre Deeke, et al.
Publicado: (2017)

Treatment sequencing in metastatic castrate-resistant prostate cancer
por: Sartor, Oliver, et al.
Publicado: (2014)

Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC)
por: Luz, Murilo de Almeida, et al.
Publicado: (2021)

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
por: Merriel, Samuel W.D., et al.
Publicado: (2019)

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
por: Gillessen, S., et al.
Publicado: (2015)

Management of advanced prostate cancer in a middle‐income country: real‐world consideration of the Advanced Prostate Cancer Consensus Conference 2017
por: Saad, Marniza, et al.
Publicado: (2019)

No consensus about consensus?
por: Kappos, Ludwig
Publicado: (2021)

Developing a consensus statement for psychosocial support in active surveillance for prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2022)

Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil
por: de Andrade, Diocésio Alves Pinto, et al.
Publicado: (2023)

Consensus Statement on Proton Therapy for Prostate Cancer
por: Bryant, Curtis M., et al.
Publicado: (2021)

What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
por: Turco, Fabio, et al.
Publicado: (2022)

Second brazilian consensus on the treatment of advanced prostate cancer: a SBOC-SBU-SBRT panel review
por: Sasse, Andre Deeke, et al.
Publicado: (2019)

Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy
por: Verzoni, Elena, et al.
Publicado: (2022)

Management of patients with advanced prostate cancer in Japan: ‘real-world’ consideration of the results from the Advanced Prostate Cancer Consensus Conference
por: Fujita, Kazutoshi, et al.
Publicado: (2022)

Consensus Procedures in Oncological Imaging: The Case of Prostate Cancer
por: Fanti, Stefano, et al.
Publicado: (2019)

Managing advanced prostate cancer in the Asia Pacific region: “Real‐world” application of Advanced Prostate Cancer Consensus Conference 2019 statements
por: Chiong, Edmund, et al.
Publicado: (2022)

Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document
por: Lapini, Alberto, et al.
Publicado: (2019)

From the International Pediatric Sepsis Conference 2005 to the Sepsis-3 Consensus
por: de Souza, Daniela Carla, et al.
Publicado: (2018)

The impact of the 2005 International Society of Urological Pathology Gleason grading consensus on active surveillance for prostate cancer
por: Ramakrishnan, Venkat M., et al.
Publicado: (2017)

Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
por: Ong, Sean, et al.
Publicado: (2022)

PSMA theragnostics for metastatic castration resistant prostate cancer
por: Song, Hong, et al.
Publicado: (2022)

National Consensus on Non-metastatic Castration-Resistant Prostate Cancer: more than just a snapshot
por: Reis, Leonardo Oliveira, et al.
Publicado: (2021)

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

A New Spin on Research Translation: The Boston Consensus Conference on Human Biomonitoring
por: Nelson, Jessica W., et al.
Publicado: (2009)

Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations
por: Mukherji, Deborah, et al.
Publicado: (2019)

Image-guided percutaneous targeting of lymph nodes: a novel approach for salvage pelvic lymphadenectomy in recurrent prostate cancer
por: Lemos, Gustavo Caserta, et al.
Publicado: (2017)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
por: McNeel, Douglas G., et al.
Publicado: (2016)

Risk subtyping and prognostic assessment of prostate cancer based on consensus genes
por: Meng, Jialin, et al.
Publicado: (2022)

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
por: Yekedüz, Emre, et al.
Publicado: (2023)

Consensus on β-Lactamase Nomenclature
por: Bradford, Patricia A., et al.
Publicado: (2022)

The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
por: van Leenders, Geert J.L.H., et al.
Publicado: (2020)

Corrigendum to “What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021” [Eur Urol 82(1):6–11]
por: Turco, Fabio, et al.
Publicado: (2022)

Reply to Yu Wei, Yao Zhu, and Dingwei Ye's Letter to the Editor re: Fabio Turco, Andrew Armstrong, Gerhardt Attard, et al. What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021. Eur Urol. 2022;82:6–11
por: Turco, F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lhbvat92l1nnj2rncgn7s72gi9